309 related articles for article (PubMed ID: 14711605)
1. [Antidigoxin Fab fragments and digoxin monitoring: a challenge for the biologist].
Parant F; Ducluzeau R; Lardet G; Gagnieu MC; Moulsma M
Ann Biol Clin (Paris); 2003; 61(6):645-53. PubMed ID: 14711605
[TBL] [Abstract][Full Text] [Related]
2. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
Milani L; Bizzaro N; Sanson A
G Ital Cardiol; 1992 Jan; 22(1):97-101. PubMed ID: 1624074
[TBL] [Abstract][Full Text] [Related]
3. Digoxin assay anomalies due to digoxin-specific Fab immunotherapy.
Natowicz M; Shaw L
DICP; 1991; 25(7-8):739-41. PubMed ID: 1949929
[TBL] [Abstract][Full Text] [Related]
4. Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind).
Jortani SA; Pinar A; Johnson NA; Valdes R
Clin Chim Acta; 1999 May; 283(1-2):159-69. PubMed ID: 10404740
[TBL] [Abstract][Full Text] [Related]
5. [Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation].
Weller P; Peters U; Dickmanns HA; Hespe TH; Adam M; Allolio B; Smolarz A; Grabensee B
Dtsch Med Wochenschr; 1983 Sep; 108(38):1437-40. PubMed ID: 6884234
[TBL] [Abstract][Full Text] [Related]
6. Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind).
Dasgupta A; Reyes MA
Am J Clin Pathol; 2005 Aug; 124(2):229-36. PubMed ID: 16040294
[TBL] [Abstract][Full Text] [Related]
7. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance.
Zdunek M; Mitra A; Mokrzycki MH
Am J Kidney Dis; 2000 Jul; 36(1):177-83. PubMed ID: 10873888
[TBL] [Abstract][Full Text] [Related]
8. Monitoring serum digoxin concentrations during digoxin immune Fab therapy.
Ujhelyi MR; Colucci RD; Cummings DM; Green PJ; Robert S; Vlasses PH; Zarowitz BJ
DICP; 1991 Oct; 25(10):1047-9. PubMed ID: 1803787
[TBL] [Abstract][Full Text] [Related]
9. Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose.
Hursting MJ; Raisys VA; Opheim KE; Bell JL; Trobaugh GB; Smith TW
Clin Chem; 1987 Sep; 33(9):1652-5. PubMed ID: 3621567
[TBL] [Abstract][Full Text] [Related]
10. Determination of free serum digoxin concentrations in digoxin toxic patients after administration of digoxin fab antibodies.
Ujhelyi MR; Green PJ; Cummings DM; Robert S; Vlasses PH; Zarowitz BJ
Ther Drug Monit; 1992 Apr; 14(2):147-54. PubMed ID: 1585401
[TBL] [Abstract][Full Text] [Related]
11. [Severe digoxin intoxication in a 15-year-old girl treated with Fab antidigoxin].
Gómez Barrado JJ; García Rubira JC; Turégano Albarrán S; García Martínez JT; Trujillo Berraquero F; Molano Casimiro F
Rev Esp Cardiol; 1996 Apr; 49(4):311-3. PubMed ID: 8650409
[TBL] [Abstract][Full Text] [Related]
12. Free and total digoxin in serum during treatment of acute digoxin poisoning with Fab fragments: case study.
Eyer F; Steimer W; Müller C; Zilker T
Am J Crit Care; 2010 Jul; 19(4):391-87. PubMed ID: 19875723
[TBL] [Abstract][Full Text] [Related]
13. Effect of digoxin Fab antibodies on five digoxin immunoassays.
Ujhelyi MR; Cummings DM; Green P; Ellison MJ; Vlasses PH
Ther Drug Monit; 1990 May; 12(3):288-92. PubMed ID: 2349615
[TBL] [Abstract][Full Text] [Related]
14. Measuring the unbound concentration fails to resolve analytic interferences in digoxin immunoassays.
Morris RG; Jones TE; Wicks FA; Rogers NM
Ther Drug Monit; 2008 Aug; 30(4):548-52. PubMed ID: 18641559
[TBL] [Abstract][Full Text] [Related]
15. Influence of assay methods on serum concentrations of digoxin during FAB fragment treatment.
Banner W; Bach P; Burk B; Freestone S; Gooch WM
J Toxicol Clin Toxicol; 1992; 30(2):259-67. PubMed ID: 1588675
[TBL] [Abstract][Full Text] [Related]
16. Effects of digoxin immune Fab (ovine) on digoxin immunoassays.
Rainey PM
Am J Clin Pathol; 1989 Dec; 92(6):779-86. PubMed ID: 2686397
[TBL] [Abstract][Full Text] [Related]
17. Digoxin measurements following plasma ultrafiltration in two patients with digoxin toxicity treated with specific Fab fragments.
George S; Braithwaite RA; Hughes EA
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():380-2. PubMed ID: 7979107
[No Abstract] [Full Text] [Related]
18. Free and total serum digoxin concentrations in a renal failure patient after treatment with digoxin immune Fab.
Clifton GD; McIntyre WJ; Zannikos PN; Harrison MR; Chandler MH
Clin Pharm; 1989 Jun; 8(6):441-5. PubMed ID: 2743737
[No Abstract] [Full Text] [Related]
19. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.
Smith TW; Haber E; Yeatman L; Butler VP
N Engl J Med; 1976 Apr; 294(15):797-800. PubMed ID: 943040
[TBL] [Abstract][Full Text] [Related]
20. Problems in determining levels of free digoxin in patients treated with digoxin immune FAb.
Honda SA; Rios CN; Murakami L; Morita T; Scottolini AG; Bhagavan NV
J Clin Lab Anal; 1995; 9(6):407-12. PubMed ID: 8587010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
